ImmunoGen Inc (was acquired by AbbVie (NYSE: ABBV) on 12/02/2024) (IMGN) Event May 23, 2022, 10:40 UTC 10 1 comments (75% Positive) ImmunoGen, Inc. (IMGN) Announces Clinical Development Update Comment Full text
Coherus BioSciences Inc (CHRS) Event May 20, 2022, 21:18 UTC 10 1 comments (99% Neutral) COHERUS BIOSCIENCES, INC. (CHRS) Announces Regulatory Update Comment Full text
Instil Bio Inc (TIL) Event May 20, 2022, 21:08 UTC 10 1 comments (99% Neutral) Instil Bio, Inc. (TIL) Announces Regulatory Update Comment Full text
Stoke Therapeutics (STOK) Event May 20, 2022, 20:40 UTC 10 1 comments (99% Neutral) Stoke Therapeutics, Inc. (STOK) Announces Business Combination Comment Full text
Provention Bio Inc (the company became a subdivision of the company Sanofi ADR (SNY)) (PRVB) Event May 20, 2022, 20:30 UTC 10 1 comments (99% Neutral) Provention Bio, Inc. (PRVB) Announces Executive Changes Comment Full text
Chinook Therapeutics Inc (KDNY) Event May 20, 2022, 20:11 UTC 10 1 comments (70% Positive) Chinook Therapeutics, Inc. (KDNY) Provides Update on reductions for kidney diseases Comment Full text
Aurinia Pharmaceuticals Inc (AUPH) Event May 20, 2022, 20:06 UTC 9 1 comments (99% Neutral) Aurinia Pharmaceuticals Inc. (AUPH) Files Form 8-K Comment Full text
Aeglea BioTherapeutics Inc (was renamed to Spyre Therapeutics (SYRE)) (AGLE) Event May 20, 2022, 20:05 UTC 10 1 comments (99% Neutral) AEGLEA BIOTHERAPEUTICS, INC. (AGLE) Announces Business Combination Comment Full text
AstraZeneca (AZN) Event May 20, 2022, 15:26 UTC 9 1 comments (99% Neutral) AstraZeneca (AZN) Files Form 6-K Comment Full text
TherapeuticsMD Inc (TXMD) Event May 20, 2022, 14:30 UTC 10 1 comments (99% Positive) TherapeuticsMD, Inc. (TXMD) Announces Clinical Development Update Comment Full text